Survival in mycosis fungoides (MF) is varied and may be poor. The PROCLIPI (PROspective Cutaneous Lymphoma International Prognostic Index) study is a web-based data collection system for early-stage MF with legal data-sharing agreements permitting international collaboration in a rare cancer with complex pathology. Clinicopathological data must be 100% complete and in-built intelligence in the database system ensures accurate staging
Advanced-stage mycosis fungoides (MF; stage IIB to IV) and Sézary syndrome (SS) are aggressive lymph...
BACKGROUND The PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) Study is ...
BACKGROUND The PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) Study is ...
Survival in mycosis fungoides (MF) is varied and may be poor. The PROCLIPI (PROspective Cutaneous Ly...
Survival in mycosis fungoides (MF) is varied and may be poor. PROCLIPI (PROspective Cutaneous Lympho...
BACKGROUND: Survival in mycosis fungoides (MF) is varied and may be poor. The PROCLIPI (PROspective...
BACKGROUND: Survival in mycosis fungoides (MF) is varied and may be poor. The PROCLIPI (PROspective...
BACKGROUND: Survival in mycosis fungoides (MF) is varied and may be poor. The PROCLIPI (PROspective ...
Background: Survival in mycosis fungoides (MF) is varied and may be poor. The PROCLIPI (PROspective ...
Background Survival in mycosis fungoides (MF) is varied and may be poor. The PROCLIPI (PROspective C...
Background Survival in mycosis fungoides (MF) is varied and may be poor. The PROCLIPI (PROspective C...
BACKGROUND Survival in mycosis fungoides (MF) is varied and may be poor. The PROCLIPI (PROspectiv...
BACKGROUND Survival in mycosis fungoides (MF) is varied and may be poor. The PROCLIPI (PROspectiv...
Background: The PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) Study is a ...
Background The PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study is a p...
Advanced-stage mycosis fungoides (MF; stage IIB to IV) and Sézary syndrome (SS) are aggressive lymph...
BACKGROUND The PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) Study is ...
BACKGROUND The PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) Study is ...
Survival in mycosis fungoides (MF) is varied and may be poor. The PROCLIPI (PROspective Cutaneous Ly...
Survival in mycosis fungoides (MF) is varied and may be poor. PROCLIPI (PROspective Cutaneous Lympho...
BACKGROUND: Survival in mycosis fungoides (MF) is varied and may be poor. The PROCLIPI (PROspective...
BACKGROUND: Survival in mycosis fungoides (MF) is varied and may be poor. The PROCLIPI (PROspective...
BACKGROUND: Survival in mycosis fungoides (MF) is varied and may be poor. The PROCLIPI (PROspective ...
Background: Survival in mycosis fungoides (MF) is varied and may be poor. The PROCLIPI (PROspective ...
Background Survival in mycosis fungoides (MF) is varied and may be poor. The PROCLIPI (PROspective C...
Background Survival in mycosis fungoides (MF) is varied and may be poor. The PROCLIPI (PROspective C...
BACKGROUND Survival in mycosis fungoides (MF) is varied and may be poor. The PROCLIPI (PROspectiv...
BACKGROUND Survival in mycosis fungoides (MF) is varied and may be poor. The PROCLIPI (PROspectiv...
Background: The PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) Study is a ...
Background The PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study is a p...
Advanced-stage mycosis fungoides (MF; stage IIB to IV) and Sézary syndrome (SS) are aggressive lymph...
BACKGROUND The PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) Study is ...
BACKGROUND The PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) Study is ...